Jun 26, 2025, 12:58
Welcoming Opposition to ISTH 2025: EHC Highlights the Crucial Role of Modern Treatments in Hemophilia Management
The European Haemophilia Consortium shared a post on X:
”The EHC attended ISTH 2025, where Maria Elisa Mancuso & Mark Skinner presented manuscripts we co-authored opposing the ISTH Guidelines. Thanks, Maria Elisa Mancuso (EHC Medical Advisory Group Chair), for representing our community at this pivotal moment!”
Apparently, no field is safe from a clash of clans!
The European Haemophilia Consortium eagerly took the stage to brand the ISTH guidelines as “outdated and purposeless” when it comes to acknowledging ”Modern Hemophilia Treatments”.
Maria Elisa Mancuso, Chair of the EHC Medical Advisory Group, and Mark Skinner presented sharply contrasting manuscripts that stirred the debate.
Stay updated on the World of Hemophilia with Hemostasis Today.
-
Apr 10, 2026, 18:22Chris Hillis: Reflections on My Term as President of the Canadian Hematology Society
-
Apr 10, 2026, 17:59Michelle Leona Cecil: Representing Microhealth at The Coalition for Hemophilia B Annual Symposium
-
Apr 10, 2026, 17:47Lucie Raskin: Comparing VTE Risk in Hormonal Contraceptives at NTHC 2026
-
Apr 10, 2026, 17:39Diverse Voices But Shared Mission – Day 1 of EHC Youth Leadership Workshop
-
Apr 10, 2026, 17:30Make Your Mark at the World Stroke Congress 2026 – World Stroke Organization
-
Apr 10, 2026, 17:23Sofie Abels: Implications for Targeted Screening for Thrombophilia in Young Stroke Patients
-
Apr 10, 2026, 17:08Armghan Ans: 3 Questions Worth Sitting with If You Work in Stroke AI
-
Apr 10, 2026, 17:03William Wallace: Vitamin C Is More Than ”Immune Support”
-
Apr 10, 2026, 16:58Wolfgang Miesbach: Greater Symptom Burden in Women with Bleeding Disorders – Insights from Irish Data